BioCryst Pharmaceuticals, Inc. Financial Ratios — BCRX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-59.43	-55.97	-56.64	-48.66	-33.19	-51.97	-49.07	-62.29	-67.61	-71.69	-39.89	-43.42	-42.46	-17.65	52.53
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-33.76
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	103.13
Gross Margin (%)	100	99.5	99.43	99.1	96.07	89.76	93.24	97.72	91.6	90.59	95.38	97.57	98.65	97.28	97.82
EBITDA Margin (%)	-247.93	-119.81	-175.48	-335.05	-81.36	-182.61	-225.15	-452.48	-202.17	-976.92	-112.58	-54.28	-30.79	-0.29	39.14
Operating Margin (%)	-252.44	-122.2	-177.24	-336.35	-81.74	-184.45	-227.95	-456.2	-203.66	-981.12	-113.08	-54.81	-31.29	-0.56	38.98
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	81
Pretax Margin (%)	-289.91	-148.64	-173.72	-332.08	-89.15	-209.25	-261.18	-490.25	-222.99	-1,026.35	-115.68	-90.24	-68.26	-19.29	30.56
Profit Margin (%)	-289.91	-148.64	-173.72	-332.08	-89.15	-209.25	-261.18	-490.25	-222.99	-1,026.35	-117.11	-91.24	-68.36	-19.72	30.16
Net Income to Common Margin (%)	-289.91	-148.64	-173.72	-332.08	-89.15	-209.25	-261.18	-490.25	-222.99	-1,026.35	-117.11	-91.24	-68.36	-19.72	30.16
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.32
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	30	30	30	30	30	54	55	62	85	280	593	741	825	809	439
ST Debt	- -	- -	- -	30	28	28	35	34	40	31	2	2	3	3	2
LT Debt	30	30	30	- -	2	25	20	28	45	248	591	739	822	806	437
Total Debt/EBITDA	-0.62	-0.95	-0.99	-0.66	-0.77	-1.12	-0.96	-0.66	-0.86	-1.61	-3.35	-5.04	-8.09	-623.55	1.28
Net Debt/EBITDA	-0.28	-0.29	-0.29	0.54	0.03	-0.6	-0.03	-0.35	0.35	-0.01	-0.46	-2.92	-6.87	-532.93	0.99
Total Debt/EBIT	-0.6	-0.93	-0.98	-0.66	-0.77	-1.11	-0.95	-0.66	-0.85	-1.6	-3.34	-5	-7.96	-318.03	1.29
Net Debt/EBIT	-0.27	-0.28	-0.29	0.54	0.03	-0.59	-0.03	-0.34	0.34	-0.01	-0.46	-2.89	-6.76	-271.81	0.99
EBITDA to Interest Expense	-12.9	-6.75	-6.37	-9.12	-7.55	-7.42	-6.62	-10.18	-8.3	-12	-2.98	-1.48	-0.94	-0.01	4.34
EBITDA-CapEx/Interest Expense	-12.92	-6.78	-6.37	-9.14	-8.54	-8.23	-6.66	-10.22	-8.33	-12.04	-3.02	-1.5	-0.96	-0.02	4.31
EBIT to Interest Expense	-13.14	-6.89	-6.43	-9.16	-7.59	-7.49	-6.7	-10.27	-8.36	-12.05	-3	-1.5	-0.96	-0.03	4.32
Interest Expense	4	5	5	5	5	6	9	9	12	15	59	99	108	99	79
Common Equity/Total Assets	-429.48	-682.62	-863.83	-341.32	-416.96	-629.21	-353.9	-497.73	-478.71	-305.24	-204.99	-264.13	-324.8	-360.5	-292.53
Long-Term Debt/Equity (%)	202.62	- -	- -	- -	4.98	1,614.77	23.28	57.02	116.84	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-9.29	-8.29	-7.65	- -	-0.49	-4.98	-3.38	-4.2	-5.92	-33.46	-96.57	-103.91	-96.32	-84.02	-41.05
Long-Term Debt/Total Assets (%)	36.49	52.23	61.39	- -	1.94	28.36	10.94	19.12	25.5	74.19	100.56	134.38	159.1	164.34	85.04
Total Debt/Equity (%)	202.62	-6,607.93	-2,664.3	39.66	63.24	3,404.56	65.33	125.57	221.3	-1,451.05	-554.5	-251.68	-181.14	-169.93	-368.33
Total Debt/Capital (%)	-9.29	-8.29	-7.65	-6.86	-6.29	-10.5	-9.5	-9.24	-11.22	-37.66	-96.87	-104.24	-96.63	-84.31	-41.2
Total Debt/Total Assets (%)	36.49	52.23	61.39	21.92	24.66	59.79	30.7	42.1	48.3	83.5	100.86	134.81	159.62	164.91	85.36
Net Debt to Equity	91.56	-2,006.39	-784.72	-32.45	-2.29	1,832.45	1.93	65.69	-89.67	-12.07	-75.77	-145.46	-153.8	-145.23	-283.25
Net Debt/Capital (%)	-3.99	-2.38	-2.14	4.99	0.22	-5.42	-0.26	-4.65	3.95	-0.23	-7.26	-42.17	-72.63	-64.97	-29.22
EBITDA	-49	-32	-30	-46	-39	-48	-57	-93	-99	-174	-177	-147	-102	-1	342
EBITDA-CapEx	-49	-32	-30	-46	-44	-53	-57	-94	-99	-175	-179	-148	-104	-2	340
Operating Income (Loss)	-50	-32	-31	-46	-39	-49	-57	-94	-99	-175	-178	-148	-104	-3	341

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.59	2.07	2.49	1.27	0.83	1.01	1.53	1.5	1.48	2.84	4.89	4.02	2.59	2	1.4
Current Ratio	2.01	2.44	2.76	1.56	1.02	1.23	1.68	1.65	1.78	3.06	5.46	4.9	3.31	2.63	2.06
Quick Ratio	1.87	2.33	2.63	1.44	0.93	1.17	1.61	1.57	1.72	2.92	5.18	4.5	2.97	2.49	1.95
CFO/Avg Current Liab	-1.19	-1.72	-1.63	-1.06	-0.22	-0.92	-0.64	-1.28	-1.11	-1.36	-1.36	-1.55	-0.74	-0.34	1.95
Common Equity/Total Assets	-429.48	-682.62	-863.83	-341.32	-416.96	-629.21	-353.9	-497.73	-478.71	-305.24	-204.99	-264.13	-324.8	-360.5	-292.53
Long-Term Debt/Equity (%)	202.62	- -	- -	- -	4.98	1,614.77	23.28	57.02	116.84	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-9.29	-8.29	-7.65	- -	-0.49	-4.98	-3.38	-4.2	-5.92	-33.46	-96.57	-103.91	-96.32	-84.02	-41.05
Long-Term Debt/Total Assets (%)	36.49	52.23	61.39	- -	1.94	28.36	10.94	19.12	25.5	74.19	100.56	134.38	159.1	164.34	85.04
Total Debt/Equity (%)	202.62	-6,607.93	-2,664.3	39.66	63.24	3,404.56	65.33	125.57	221.3	-1,451.05	-554.5	-251.68	-181.14	-169.93	-368.33
Total Debt/Capital (%)	-9.29	-8.29	-7.65	-6.86	-6.29	-10.5	-9.5	-9.24	-11.22	-37.66	-96.87	-104.24	-96.63	-84.31	-41.2
Total Debt/Total Assets (%)	36.49	52.23	61.39	21.92	24.66	59.79	30.7	42.1	48.3	83.5	100.86	134.81	159.62	164.91	85.36
CFO/Total Liabilities	-47.85	-64.6	-53.07	-62.95	-17.57	-60.54	-43.54	-94.84	-65.38	-38.17	-20.45	-19.16	-9.78	-5.38	54.85
CFO/CapEx	-586.38	-330.95	-884.33	-363.69	-2.56	-10.13	-125.44	-252.91	-261.18	-262.86	-59.6	-119.8	-43.88	-46.28	140.75
Altman's Z-Score	-6.39	-9.71	-8.13	2.45	-0.45	-6.97	-2.91	-3.47	-6.07	-3.06	-0.52	-1.69	-3.06	-2.55	1.83

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	1.09	5.06	5.19	2.35	6.13	3.51	3.38	3.97	3.69	1.16	8.26	6.77	6.16	6.63	9.41
Days Sales Outstanding	335.01	72.14	70.31	155.64	59.5	103.95	107.86	91.99	98.8	315.49	44.19	53.92	59.22	55.08	38.78
Inventory Turnover	- -	1	- -	0.36	1.65	2.56	6.81	0.57	4.97	0.48	0.64	0.3	0.16	0.67	2.83
Days Inventory Outstanding	- -	363.62	- -	1,021.7	220.91	142.81	53.61	638.94	73.38	766.48	573.58	1,199.06	2,289.54	546.95	129.02
Accounts Payable Turnover	-0.12	-0.04	0.02	0.23	0.46	0.23	0.23	0.3	0.23	0.53	0.69	0.87	0.32	-0.51	1.19
Accounts Payable Turnover Days	-3,074.62	-9,014.94	15,173.57	1,592.17	785.3	1,561.2	1,610.31	1,214.31	1,619.35	684.79	530.1	419.66	1,142.42	-713.1	305.95
Cash Conversion Cycle	- -	9,450.7	-15,103.26	-414.83	-504.89	-1,314.43	-1,448.84	-483.38	-1,447.17	397.18	87.67	833.32	1,206.35	1,315.13	-138.15
Inventory to Cash Days	- -	-291.48	70.31	-866.06	-161.41	-38.85	54.24	-546.96	25.42	-450.99	-529.39	-1,145.15	-2,230.31	-491.87	-90.24
Inventories	- -	- -	- -	1	2	- -	- -	2	- -	7	16	28	29	8	5
Raw Materials	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	9	6	10	10
Work In Process	- -	- -	- -	- -	2	- -	- -	- -	- -	3	10	15	18	16	13
Finished Goods	4	4	4	- -	- -	- -	- -	- -	- -	5	1	5	6	8	7
Other Inventory	- -	- -	- -	- -	- -	- -	- -	2	- -	- -	- -	- -	- -	-23	-24

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	112	70	420	812	752	467	415	833	399	1,246	2,481	2,134	1,151	1,554	1,637
- Cash & Cash Equivalents	16	21	21	55	29	22	50	27	114	272	504	305	111	105	90
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	30	30	30	30	30	54	55	62	85	280	593	741	825	809	439
Enterprise Value	100	65	412	769	731	466	355	790	347	1,225	2,566	2,451	1,587	2,042	1,801
Total Capital	-323	-362	-392	-437	-480	-512	-576	-669	-754	-742	-612	-711	-854	-959	-1,065
Total Debt/Capital (%)	-9.29	-8.29	-7.65	-6.86	-6.29	-10.5	-9.5	-9.24	-11.22	-37.66	-96.87	-104.24	-96.63	-84.31	-41.2
Total Debt / EV	0.3	0.46	0.07	0.04	0.04	0.12	0.15	0.08	0.24	0.23	0.23	0.3	0.52	0.4	0.24
EV/Sales	5.08	2.46	23.75	56.52	15.15	17.67	14.09	38.25	7.11	68.79	16.33	9.05	4.79	4.53	2.06
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.26
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.28
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	119.84	41.95	4.24
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	102.98	41.01	4.21
Diluted Market Cap	112	70	420	812	752	467	415	833	399	1,246	2,481	2,134	1,151	1,554	1,705
Diluted Enterprise Value	125	79	428	787	754	498	419	868	369	1,254	2,570	2,571	1,866	2,258	2,054
EV per Share	2.21	1.31	7.45	11.52	10.03	6.32	4.2	7.66	3	7.33	14.33	13.19	8.26	9.88	8.58
TTM Sales	20	26	17	14	48	26	25	21	49	18	157	271	331	451	875
TTM EBITDA	-49	-32	-30	-46	-39	-48	-57	-93	-99	-174	-177	-147	-102	-1	342
TTM Operating Income	-50	-32	-31	-46	-39	-49	-57	-94	-99	-175	-178	-148	-104	-3	341
TTM Cash Flow to Firm	-28	-33	-22	-34	-8	-47	-33	-83	-78	-121	-82	-62	13	49	425
TTM Free Cash Flow to Firm	-28	-33	-22	-33	-3	-42	-32	-83	-77	-120	-80	-60	15	50	428

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-3.46	-1.88	-15.84	-21.12	-94.11	-9.69	-10.16	-9.03	-4.47	-9.26	-17.75	-13.3	-12.38	-30.54	4.87
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.28
Enterprise Value	100	65	412	769	731	466	355	790	347	1,225	2,566	2,451	1,587	2,042	1,801
Low Price	2.28	1.08	1.12	7.29	7.85	1.63	3.95	4.25	1.38	1.58	7.27	7.61	4.82	4.03	6
EV/Sales	5.08	2.46	23.75	56.52	15.15	17.67	14.09	38.25	7.11	68.79	16.33	9.05	4.79	4.53	2.06
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.26
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.2
Price/Earnings Average	-2.71	-4.58	-6.75	-16.15	-19.09	-5.58	-7.38	-6.41	-5.31	-3.71	-12.9	-9.72	-6.49	-15.35	6.54
Price/Earnings High	-4.3	-7.53	-14.38	-21.6	-28.52	-13.69	-11.88	-9.9	-10.56	-8.23	-17.98	-15.04	-10.25	-20.65	9
Price/Earnings Low	-1.81	-1.37	-2.05	-10.77	-13.3	-2.18	-5.07	-4.33	-1.46	-1.45	-7.07	-5.73	-4.09	-9.37	4.77
Price/Book Value	-0.32	-0.18	-0.99	-1.74	-1.47	-0.83	-0.66	-1.14	-0.48	-1.22	-2.06	-1.47	-0.69	-0.88	-1.09
Price/Book Value Average	-0.44	-0.46	-0.48	-1.56	-1.61	-0.54	-0.77	-0.89	-0.69	-0.66	-1.97	-1.65	-0.88	-0.77	-1.15
Price/Book Value High	-0.69	-0.75	-1.03	-2.09	-2.4	-1.33	-1.24	-1.37	-1.37	-1.47	-2.75	-2.56	-1.38	-1.04	-1.58
Price/Book Value Low	-0.29	-0.14	-0.15	-1.04	-1.12	-0.21	-0.53	-0.6	-0.19	-0.26	-1.08	-0.97	-0.55	-0.47	-0.84
Price/Tangible Book Value	7.53	-154.74	-372.68	10.74	15.76	295.64	4.95	16.91	10.43	-64.69	-23.19	-7.24	-2.53	-3.27	-13.74
Price/Tangible Book Value Average	10.41	-394.67	-180.4	9.65	17.2	195.07	5.8	13.18	15.13	-35.23	-22.2	-8.15	-3.23	-2.87	-14.49
Price/Tangible Book Value High	16.56	-648.39	-384.45	12.91	25.71	478.25	9.33	20.35	30.07	-78.07	-30.94	-12.61	-5.1	-3.86	-19.92
Price/Tangible Book Value Low	6.95	-117.69	-54.92	6.44	11.99	76.13	3.98	8.91	4.17	-13.72	-12.17	-4.8	-2.04	-1.75	-10.57
Price/Sales	5.68	2.67	24.21	59.67	15.59	17.7	16.46	40.32	8.17	69.96	15.78	7.88	3.47	3.45	1.87
Price/Sales Average	7.85	6.81	11.72	53.64	17.01	11.68	19.27	31.43	11.85	38.1	15.11	8.87	4.44	3.03	1.97
Price/Sales High	12.48	11.2	24.98	71.74	25.42	28.64	31.02	48.51	23.55	84.42	21.06	13.72	7.01	4.07	2.71
Price/Sales Low	5.24	2.03	3.57	35.77	11.86	4.56	13.24	21.23	3.27	14.84	8.29	5.22	2.8	1.85	1.44
Price/Cash Flow	-3.46	-1.88	-15.82	-21.06	-57.36	-8.73	-10.08	-9	-4.45	-9.22	-17.45	-13.19	-12.1	-29.88	4.71
Price/Cash Flow Average	-4.78	-4.79	-7.66	-18.93	-62.6	-5.76	-11.8	-7.01	-6.46	-5.02	-16.71	-14.84	-15.45	-26.22	4.97
Price/Cash Flow High	-7.6	-7.87	-16.32	-25.32	-93.54	-14.12	-18.99	-10.82	-12.84	-11.13	-23.28	-22.96	-24.4	-35.28	6.83
Price/Cash Flow Low	-3.19	-1.43	-2.33	-12.63	-43.63	-2.25	-8.11	-4.74	-1.78	-1.96	-9.16	-8.74	-9.75	-16.01	3.63
Price/Free Cash Flow Average	-4.79	-4.81	-7.67	-18.99	-102.71	-6.39	-11.89	-7.04	-6.48	-5.04	-16.99	-14.97	-15.81	-26.8	5.14
Price/Free Cash Flow High	-7.61	-7.9	-16.34	-25.39	-153.48	-15.67	-19.14	-10.87	-12.89	-11.17	-23.68	-23.15	-24.97	-36.06	7.07
Price/Free Cash Flow Low	-3.2	-1.43	-2.33	-12.66	-71.59	-2.49	-8.17	-4.76	-1.79	-1.96	-9.32	-8.81	-9.97	-16.37	3.75
EV/Sales Average	8.54	7.16	12.23	51.83	17.04	12.88	19.45	33.12	11.24	38.51	15.68	10.48	6.59	4.59	2.37
EV/Sales High	13.17	11.54	25.49	69.94	25.45	29.84	31.19	50.21	22.95	84.84	21.63	15.33	9.16	5.63	3.11
EV/Sales Low	5.93	2.38	4.08	33.97	11.89	5.76	13.42	22.93	2.66	15.25	8.85	6.84	4.95	3.41	1.84
EV/EBITDA Average	-3.44	-5.98	-6.97	-15.47	-20.94	-7.05	-8.64	-7.32	-5.56	-3.94	-13.92	-19.31	-21.41	-1,594.53	6.06
EV/EBITDA High	-5.31	-9.63	-14.52	-20.87	-31.28	-16.34	-13.85	-11.1	-11.35	-8.68	-19.21	-28.25	-29.75	-1,957.97	7.95
EV/EBITDA Low	-2.39	-1.99	-2.32	-10.14	-14.61	-3.15	-5.96	-5.07	-1.32	-1.56	-7.86	-12.6	-16.09	-1,185.05	4.7
EV/EBIT Average	-3.38	-5.86	-6.9	-15.41	-20.85	-6.98	-8.53	-7.26	-5.52	-3.93	-13.86	-19.13	-21.06	-813.25	6.09
EV/EBIT High	-5.22	-9.45	-14.38	-20.79	-31.14	-16.18	-13.68	-11.01	-11.27	-8.65	-19.13	-27.98	-29.28	-998.62	7.99
EV/EBIT Low	-2.35	-1.95	-2.3	-10.1	-14.54	-3.12	-5.89	-5.03	-1.31	-1.55	-7.83	-12.47	-15.83	-604.41	4.72
Last Price	2.47	1.42	7.6	12.16	10.32	6.33	4.91	8.07	3.45	7.45	13.85	11.48	5.99	7.52	7.8
High Price	5.43	5.95	7.84	14.62	16.83	10.24	9.25	9.71	9.95	8.99	18.48	19.99	12.08	8.88	11.31
Enterprise Value Average	168	188	212	705	822	339	490	684	549	686	2,464	2,839	2,185	2,068	2,076
Enterprise Value High	259	303	442	952	1,228	786	786	1,037	1,121	1,511	3,399	4,153	3,036	2,539	2,723
Enterprise Value Low	116	63	71	462	574	152	338	474	130	272	1,391	1,851	1,642	1,537	1,608

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	46	51	59	72	73	74	98	110	154	177	184	188	206	209	213
Diluted Weighted Avg Shares	45	49	55	67	73	74	84	103	116	167	179	186	192	207	219
Basic Weighted Avg Shares	45	49	55	67	73	74	84	103	116	167	179	186	192	207	210
Revenue per Share	0.44	0.53	0.31	0.2	0.66	0.36	0.3	0.2	0.42	0.11	0.88	1.46	1.72	2.18	4.17
EBITDA per Share	-1.08	-0.64	-0.55	-0.68	-0.54	-0.65	-0.67	-0.91	-0.85	-1.04	-0.99	-0.79	-0.53	-0.01	1.63
Operating Income per Share	-1.1	-0.65	-0.56	-0.69	-0.54	-0.66	-0.68	-0.91	-0.86	-1.04	-0.99	-0.8	-0.54	-0.01	1.62
Basic EPS, GAAP	-1.26	-0.79	-0.55	-0.68	-0.59	-0.75	-0.78	-0.98	-0.94	-1.09	-1.03	-1.33	-1.18	-0.43	1.26
Basic EPS from Cont Ops	-1.26	-0.79	-0.55	-0.68	-0.59	-0.75	-0.78	-0.98	-0.94	-1.09	-1.03	-1.33	-1.18	-0.43	1.26
Diluted EPS, GAAP	-1.26	-0.79	-0.55	-0.68	-0.59	-0.75	-0.78	-0.98	-0.94	-1.09	-1.03	-1.33	-1.18	-0.43	1.21
Diluted EPS from Cont Ops	-1.26	-0.79	-0.55	-0.68	-0.59	-0.75	-0.78	-0.98	-0.94	-1.09	-1.03	-1.33	-1.18	-0.43	1.21
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.71	-0.76	-0.48	-0.58	-0.18	-0.73	-0.49	-0.9	-0.77	-0.81	-0.79	-0.87	-0.5	-0.25	1.65
Free Cash Flow per Basic Share	-0.72	-0.76	-0.48	-0.58	-0.25	-0.8	-0.49	-0.9	-0.78	-0.81	-0.81	-0.88	-0.51	-0.26	1.64
Cash & Equivalents per Share	0.92	0.72	0.69	1.09	0.71	0.74	1.35	1.01	1.18	1.8	2.83	2.28	2.02	1.55	1.31
Book Value per Share	-7.82	-7.93	-7.64	-7	-7	-7.67	-7.47	-7.08	-7.26	-6.11	-6.73	-7.81	-8.74	-8.55	-7.17
Tangible Book Value per Share	0.33	-0.01	-0.02	1.13	0.65	0.02	0.99	0.48	0.33	-0.12	-0.6	-1.58	-2.37	-2.3	-0.57

BioCryst Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)